As CEO of Milo Health, Chems Hachani brings over 10 years of extensive experience in clinical research, having successfully led numerous clinical studies throughout his career. Previously, he directed a clinical research company, scaling it to achieve 3 million euros in revenue. At Milo Health, Chems drives the strategy to automate patient data capture and trial matching, significantly enhancing the efficiency and accuracy of clinical trials. His leadership is pivotal in advancing Milo Health's mission to revolutionize the clinical trial process, making it more streamlined and effective for better patient outcomes.